Literature DB >> 9261366

Cyclin-dependent kinase regulation of the replication functions of polyomavirus large T antigen.

H Li1, S Bhattacharyya, C Prives.   

Abstract

The amino-terminal portion of polyomavirus (Py) large T antigen (T Ag) contains two phosphorylation sites, at T187 and T278, which are potential substrates for cyclin-dependent kinases (CDKs). Our experiments were designed to test whether either or both of these sites are involved in the origin DNA (ori DNA) replication function of Py T Ag. Mutations were generated in Py T Ag whereby either or both threonines were replaced with alanine, generating T187A, T278A, and double-mutants (DM [T187A T278A]) mutant T Ags. We found that the Py ori DNA replication functions of T278A and DM, but not T187A, mutant T Ags were abolished both in vivo and in vitro. Consistent with this finding, it was shown that the ori DNA binding and unwinding activities of mutant T278A Py T Ag were greatly impaired. Moreover, whereas wild-type Py T Ag is an efficient substrate for phosphorylation by cyclin A-CDK2 and cyclin B-cdc2 complexes, it is phosphorylated poorly by a cyclin E-CDK2 complex. In contrast to mutant T187A, which behaved similarly to the wild-type protein, T278A was only weakly phosphorylated by cyclin B-cdc2. These data thus suggest that T278 is an important site on Py T Ag for phosphorylation by CDKs and that loss of this site leads to its various defects in mediating ori DNA replication. S- and G2-phase-specific CDKs, but not a G1-specific CDK, can phosphorylate wild-type T Ag, which suggests yet another reason why DNA tumor viruses require actively cycling host cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9261366      PMCID: PMC191922     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Polyomavirus large T mutants affected in retinoblastoma protein binding are defective in immortalization.

Authors:  A Larose; N Dyson; M Sullivan; E Harlow; M Bastin
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

2.  DNA helicase and duplex DNA fragment unwinding activities of polyoma and simian virus 40 large T antigen display similarities and differences.

Authors:  E H Wang; C Prives
Journal:  J Biol Chem       Date:  1991-07-05       Impact factor: 5.157

3.  Tumor antigen(s) in cell productively infected by wild-type polyoma virus and mutant NG-18.

Authors:  B S Schaffhausen; J E Silver; T L Benjamin
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

4.  Phosphorylation of large tumour antigen by cdc2 stimulates SV40 DNA replication.

Authors:  D McVey; L Brizuela; I Mohr; D R Marshak; Y Gluzman; D Beach
Journal:  Nature       Date:  1989-10-12       Impact factor: 49.962

5.  Characterization of T antigens in polyoma-infected and transformed cells.

Authors:  M A Hutchinson; T Hunter; W Eckhart
Journal:  Cell       Date:  1978-09       Impact factor: 41.582

6.  Inhibition of SV40 replication in simian cells by specific pBR322 DNA sequences.

Authors:  M Lusky; M Botchan
Journal:  Nature       Date:  1981-09-03       Impact factor: 49.962

7.  Localization of the phosphorylations of polyomavirus large T antigen.

Authors:  B J Bockus; B Schaffhausen
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

8.  A predictive scale for evaluating cyclin-dependent kinase substrates. A comparison of p34cdc2 and p33cdk2.

Authors:  J K Holmes; M J Solomon
Journal:  J Biol Chem       Date:  1996-10-11       Impact factor: 5.157

9.  Molecular cloning of the cDNAs for the four subunits of mouse DNA polymerase alpha-primase complex and their gene expression during cell proliferation and the cell cycle.

Authors:  H Miyazawa; M Izumi; S Tada; R Takada; M Masutani; M Ui; F Hanaoka
Journal:  J Biol Chem       Date:  1993-04-15       Impact factor: 5.157

10.  The replication functions of polyomavirus large tumor antigen are regulated by phosphorylation.

Authors:  E H Wang; S Bhattacharyya; C Prives
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

View more
  7 in total

1.  Interaction between cyclin-dependent kinases and human papillomavirus replication-initiation protein E1 is required for efficient viral replication.

Authors:  T Ma; N Zou; B Y Lin; L T Chow; J W Harper
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

2.  Phosphorylation of simian virus 40 T antigen on Thr 124 selectively promotes double-hexamer formation on subfragments of the viral core origin.

Authors:  B A Barbaro; K R Sreekumar; D R Winters; A E Prack; P A Bullock
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Roscovitine, a specific inhibitor of cellular cyclin-dependent kinases, inhibits herpes simplex virus DNA synthesis in the presence of viral early proteins.

Authors:  L M Schang; A Rosenberg; P A Schaffer
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

4.  Transcription of herpes simplex virus immediate-early and early genes is inhibited by roscovitine, an inhibitor specific for cellular cyclin-dependent kinases.

Authors:  L M Schang; A Rosenberg; P A Schaffer
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

5.  Polyomavirus large T antigen induces alterations in cytoplasmic signalling pathways involving Shc activation.

Authors:  V Gottifredi; G Pelicci; E Munarriz; R Maione; P G Pelicci; P Amati
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

6.  Pharmacological cyclin-dependent kinase inhibitors inhibit replication of wild-type and drug-resistant strains of herpes simplex virus and human immunodeficiency virus type 1 by targeting cellular, not viral, proteins.

Authors:  Luis M Schang; Andrew Bantly; Marie Knockaert; Farida Shaheen; Laurent Meijer; Michael H Malim; Nathanael S Gray; Priscilla A Schaffer
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

7.  Fecal, oral, blood and skin virome of laboratory rabbits.

Authors:  Yuqing Xiao; Hao Wang; Lei Feng; Jiamin Pan; Zeyu Chen; Huiling Wang; Shixing Yang; Quan Shen; Xiaochun Wang; Tongling Shan; Wen Zhang
Journal:  Arch Virol       Date:  2020-10-09       Impact factor: 2.574

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.